Skip to main content
OpenTrials

Clinical trial condition

Advanced Renal Cell Carcinoma (RCC)

Explore clinical trials studying Advanced Renal Cell Carcinoma (RCC). Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Advanced Renal Cell Carcinoma (RCC) trial results

Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

NCT07293351

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma (RCC), Carcinoma, +14 more
Locations
  • Local Institution - 0178 Palo Alto, California, United States
  • Local Institution - 0117 New Haven, Connecticut, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Local Institution - 0177 Miami, Florida, United States
View all 91 locations
View Trial Details

Related conditions